Retavase

Product manufactured by Chiesi Usa, Inc.

Application Nr Approved Date Route Status External Links
BLA103786 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Retavase Is Indicated For Use In Acute St-Elevation Myocardial Infarction (Stemi) To Reduce The Risk Of Death And Heart Failure. Limitation Of Use: The Risk Of Stroke May Outweigh The Benefit Produced By Thrombolytic Therapy In Patients Whose Stemi Puts Them At Low Risk For Death Or Heart Failure. Retavase Is A Tissue Plasminogen Activator (Tpa) Indicated For Treatment Of Acute St-Elevation Myocardial Infarction (Stemi) To Reduce The Risk Of Death And Heart Failure. ( 1 ) Limitation Of Use: The Risk Of Stroke May Outweigh The Benefit Produced By Thrombolytic Therapy In Patients Whose Stemi Puts Them At Low Risk For Death Or Heart Failure. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Reteplase

Comments